Deutsche Bank
KRSA

Deutsche Bank’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Deutsche Bank’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-471
Closed -$257K – 4440
2021
Q2 		$257K Sell
471
-108
-19% -$6.76K ﹤0.01% 3639
2021
Q1 		$226K Buy
579
+467
+417% +$35.1K ﹤0.01% 3569
2020
Q4 		$48K Buy
112
+27
+32% +$1.84K ﹤0.01% 4121
2020
Q3 		$72K Buy
85
+8
+10% +$915 ﹤0.01% 3697
2020
Q2 		$64K Buy
77
+17
+28% +$1.42K ﹤0.01% 3685
2020
Q1 		$23K Sell
60
-4
-6% -$285 ﹤0.01% 3874
2019
Q4 		$23K Buy
64
+12
+23% +$1.12K ﹤0.01% 4254
2019
Q3 		$87K Sell
52
-78
-60% -$16.8K ﹤0.01% 3622
2019
Q2 		$207K Buy
+130
New +$36.8K ﹤0.01% 3803

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank's KRSA Position: Q3 2021 in Review

Deutsche Bank sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2021, closing a stake of 471 shares — an estimated $257K sold.

Deutsche Bank first reported a position in KRSA in Q2 2019 and held it in 9 quarters. The position peaked at $257K in Q2 2021. 58 funds tracked by Wall St. Rank hold KRSA as of Q3 2021.

  • Deutsche Bank reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 471 Korsana Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $257K.
  • Deutsche Bank first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
  • Deutsche Bank's Korsana Biosciences, Inc. Common Stock position peaked at $257K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.